At what stage of a cancer's presentation is the oncologist advised to deploy genomic profiling to inform clinical decision-making and therapeutic choices aligned with specific alterations and mutations?

At what stage of a cancer's presentation is the oncologist advised to deploy genomic profiling to inform clinical decision-making and therapeutic choices aligned with specific alterations and mutations?

At what stage of a cancer’s presentation or evolution is the oncologist advised to deploy genomic profiling to inform clinical decision-making and therapeutic choices aligned with specific alterations and mutations?


Created by

CMEducation Resources IQ&A Interactive Intelligence Zone

Presenter

Lia Tsimberidou, MD, PhD

Lia Tsimberidou, MD, PhD

Tenured Associate Professor
Department of Investigational Cancer Therapeutics
Division of Cancer Medicine
The University of Texas MD Anderson Cancer Center
Houston, TX